← Back to Stock Screener← Stock Screener
ZYBERNO
Stock Report
Updated Aug 28, 2026

AGILENT TECHNOLOGIES, INC. (A)

NYSE

$157.69
Agilent Technologies Inc. is an American analytical instrumentation development and manufacturing company headquartered in Santa Clara, California, that provides application-focused solutions to laboratories worldwide. Spun off from Hewlett-Packard in 1999, Agilent operates through Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab segments, offering instruments, software, services, and consumables for the entire laboratory workflow. The company's products include liquid chromatography systems, gas chromatography systems, mass spectrometry systems, spectroscopy instruments, genomics solutions, cell analysis systems, laboratory automation, software, and services used in pharmaceutical, biotechnology, diagnostics, chemical, environmental, food, forensics, academic, and clinical research laboratories. Trading on the New York Stock Exchange under ticker symbol A, Agilent serves approximately 130,000 customers in more than 110 countries with a workforce of 18,500 employees and generated $6.8 billion in revenue in fiscal 2023. The company's mission is to advance the quality of life by providing trusted answers through innovation in measurement science, serving markets including pharmaceutical drug discovery and development, clinical diagnostics, genomics research, food safety testing, environmental analysis, petrochemical analysis, and forensics.

Professional Investment Analysis

ZYBERNO SCORE →
Is it a great business? Is it getting better?
49.0/100
WEAK BUSINESS
AGILENT TECHNOLOGIES, INC. (A) scores 49/100 — weak fundamentals with mixed indicators requiring careful analysis before acting.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
MARGIN OF SAFETY
Is this stock cheap or expensive relative to what the business has historically generated for owners?
-100.0%
Overvalued
Is the market underestimating or overestimating what this business is capable of going forward?
-6.6%
Slight Overestimate
↑ UNDER
+50%
Brina Gap
-50%
↓ OVER
← OVERVALUED
-100%
Margin of Safety
UNDERVALUED →
+100%
UNDERESTIMATED
GROWTH
DOUBLE
DISCOUNT
EXPENSIVE
HYPE
VALUE
TRAP
0,0
MoS -100.0%  ·  Gap -6.6%

Two independent signals. One tells you if the stock is cheap relative to what the business has historically generated for owners — the Margin of Safety. The other tells you if the market is underestimating what the business is capable of going forward — the Brina Gap.

They are calculated from completely different data sources and answer completely different questions. The Margin of Safety reads the past. The Brina Gap reads the present economics and compares them against what the current stock price is assuming about the future.

When both point in the same direction simultaneously — DOUBLE DISCOUNT — the probability of genuine mispricing is high. The market is wrong on two independent dimensions at once, which is rare and significant.

The most dangerous scenario is not an overvalued stock — those are easy to avoid. It is a VALUE TRAP: a stock that appears cheap historically but where the market is already pricing in stronger growth than the business fundamentals support. Without the Brina Gap signal this looks identical to a genuine opportunity. The matrix separates them instantly.

The Brina Gap is the more powerful of the two signals. Most investors and analytical tools focus on valuation alone — whether a stock is cheap relative to earnings. Far fewer systematically compare what the business economics structurally support against what the stock price is actually assuming. That gap between fundamental growth potential and market expectations is where the most reliable mispricings live, and where this matrix earns its value.

Use this as your first filter. A stock in DOUBLE DISCOUNT territory is worth investigating. Everything else requires either more caution or a specific reason to act.

EXPENSIVE HYPE
In the Brina Matrix, AGILENT TECHNOLOGIES, INC. (A) registers Expensive Hype — Margin of Safety -100.0% and Brina Gap -6.6% are both unfavorable. The stock is priced above its historical earnings power and the market already assumes faster growth than the fundamentals support.
🎯 Expected Annual Return →
-22.1%
Margin of Safety convergence — your return if the market re-prices to intrinsic value (5-yr annualised)
-1.6%
Brina Gap convergence — your return if the market corrects the growth mispricing the Gap measures
11.0%
Yield + growth — what the business alone earns you, even if the market never re-rates
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):GOOD (21.5%)
Return on Capital (Capital Efficiency):EXCELLENT (96.0%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
💎
Intrinsic Value
DCF Fair Value
$46.50
🛡️
Margin of Safety
Valuation Gap
-100.0%
🎯
Expected Return
Projected Annual
-22.1%
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

According to Zyberno, AGILENT TECHNOLOGIES, INC. (A) is not a buy — WEAK BUSINESS (49/100) with a negative Margin of Safety of -100.0% and a Brina Gap of -6.6% showing the market already prices in more growth than the fundamentals support.

According to Zyberno's DCF model, AGILENT TECHNOLOGIES, INC. (A) trades at $157.69 against an estimated intrinsic value per share of $46.50 — a -100.0% Margin of Safety based on Owner Earnings of $1.11B TTM, projected at -0.5% growth for 10 years with a 2.5% terminal growth rate. The Brina Gap of -6.6% weakens the case: based on the company's ROIC (96.0%) and reinvestment rate (8.9%), the business can fundamentally grow at 8.5% — but the current enterprise value implies the market expects 15.2%. This places A in the Expensive Hype quadrant of the Brina Matrix, the most fragile combination — overvalued on cash AND overpriced on growth. Zyberno's model translates this into a 5-year expected return of -22.1% annually.

Over the trailing twelve months, A generated $1.11B in Owner Earnings. Capital was deployed as follows: $152.00M returned via share buybacks, $285.00M paid as dividends, $403.00M invested in capital expenditures. Reinvestment rate: 8.9%. Owner Earnings have declined at 0.5% annually over the trailing five years using log-linear regression.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:157.69
Market Cap:$44.47B

Valuation Multiples (3)

P/E Ratio:
31.66x
📊 Click to view full A P/E analysis →
P/S Ratio:6.15x
Peg Ratio:1.40x

Enterprise Metrics (3)

Enterprise Value:$46.02B
Ev Ebitda Ratio:24.19x
Pfcf Ratio:44.78x

Price Action & Momentum (3)

12-1 Momentum:
+21.7% (58th pctile)
📈 Click to view full A Momentum analysis →
Momentum Percentile:58 / 100
% of 52-Week High:98.2%
B. Profitability Assessment

Return Metrics (6)

ROA:11.1%
Roic:
96.0%
📊 Click to view full A ROIC analysis →
Reinvestment Rate:8.9%
Fundamental Growth Rate (g):8.5%
Market-Implied Growth Rate:15.2%
Brina Gap:
-6.6%
☷ Click to view full A Brina Gap analysis →

Margin Analysis (3)

Operating Margin Ttm:21.5%
Net Margin Ttm:19.6%
Ebitda Margin:26.3%

TTM Performance (3)

Gross Margin Ttm:52.7%
Operating Margin Ttm:21.5%
Net Margin Ttm:19.6%

Yield Metrics (3)

Earnings Yield:$3.16
Owner Earnings Yield:$2.50
Dividend Yield:0.6%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

Earnings Surprise (SUE):
+1.25
📊 Click to view full A Earnings Surprise analysis →
EPS Surprise vs Expected:47.5%
Latest Earnings Filed:2026-06-01

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):0.8%

Earnings Growth (Linear) (1)

Net Income Growth Rate (Linear):2.3%

Cash Flow Growth (Linear) (2)

Free Cash Flow Growth Rate (Linear):-4.8%
Operating Cash Flow Growth Rate (Linear):-0.1%

Operating Growth (Linear) (1)

Operating Income Growth Rate (Linear):0.6%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:2.10x
Quick Ratio:1.62x
Cash Ratio:0.80x

Leverage Analysis (1)

Debt To Ebitda:1.76x

Coverage Ratios (2)

Interest Coverage Ratio:14.09x
Times Interest Earned:14.09

Capital Structure (4)

Working Capital:2,494,000,000.00
Cash And Cash Equivalents:1,807,000,000.00
Long Term Debt:$3.05B
Net Debt:$1.55B
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $7.23B
Linear Growth: 84.0%
📊 Click to view full A Revenue analysis & methodology →
Cost Of Revenue Ttm:$3.42B

Profitability Breakdown (2)

Gross profit TTM: $3.81B
Linear Growth: 99.0%
📊 Click to view full A Gross Profit analysis & methodology →
Operating income TTM: $1.56B
Linear Growth: 64.0%
📊 Click to view full A Operating Income analysis & methodology →

Bottom Line Performance (3)

Net income TTM: $1.41B
Linear Growth: 2.3%
📊 Click to view full A Net Income analysis & methodology →
Income Before Tax:$1.58B
Ebitda Ttm:1,902,000,000.00

Operating Expenses (5)

Operating Expenses:5,677,000,000.00
R And D Expense:473,000,000.00
Sga Expense:1,786,000,000.00
Income Tax Expense:$166.00M
Interest Expense:105,000,000.00

Expense Ratios (3)

R And D To Revenue Percentage:25.8%
Sga To Revenue Percentage:97.3%
Ebitda Margin:26.3%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$13.07B
Current Assets:$4.76B
Ppe Net:2,099,000,000.00
Goodwill:4,484,000,000.00
Intangible Assets:$407.00M

Liability Structure (4)

Total Liabilities:13,267,000,000.00
Current Liabilities:2,269,000,000.00
Long Term Debt:$3.05B
Short Term Debt:$304.00M

Equity & Capital (3)

Equity:-$202.00M
Retained Earnings:$1.69B
Common Stock:2,000,000,000.00

Working Capital Items (3)

Accounts Receivable:1,498,000,000.00
Inventory:1,089,000,000.00
Accounts Payable:615,000,000.00

Special Items (2)

Contract Liabilities:855,000,000.00
Stock Based Compensation:34,000,000.00
C. Cash Flow Analysis

Operating Activities (2)

Operating cash flow TTM: $1.40B
Linear Growth: -5.0%
Free cash flow TTM: $993.00M
Linear Growth: -4.8%
📊 Click to view full A Free Cash Flow analysis & methodology →

Investment Activities (2)

Investing Cash Flow:-$93.00M
Capital Expenditures Ttm:403,000,000.00

Financing Activities (3)

Financing Cash Flow:-$222.00M
Dividends Paid Ttm:285,000,000.00
Stock Repurchase:152,000,000.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$2.00M

Non-Cash Items (1)

Depreciation Amortization Ttm:347,000,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):5.00
Eps diluted TTM: $4.98
Linear Growth: 3.9%
📊 Click to view full A EPS analysis & methodology →
Earnings Per Share Ttm:$5.01

Revenue & Cash Per Share (3)

Sales Per Share Ttm:25.65
Operating Cash Flow Per Share:$5.53
Fcf Per Share Ttm:3.52

Book Value & Capital (2)

Book Value Per Share:-$0.72
Cash Per Share:6.41

Dividend Policy (1)

Dividend Payout Ratio:22.01x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.57x
Working Capital Turnover Ttm:2.90x

Receivables Management (2)

Receivables Turnover Ttm:4.83x
Days Sales Outstanding Ttm:75.60

Inventory Management (2)

Inventory Turnover Ttm:3.14x
Days Inventory Outstanding Ttm:116.29

Payables & Cash Cycle (2)

Days Payable Outstanding:65.67
Cash Conversion Cycle:126.22
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:60.00
Quality Score:90.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (3)

Owner earnings TTM: $1.11B
Linear Growth: -54.6%
📊 Click to view full A Owner Earnings analysis & methodology →
Owner Earnings Per Share:$3.95
Owner Earnings Yield:$2.50

Growth Assessment (1)

Owner Earnings Growth Rate:-$0.55

Damodaran Growth Analysis (4)

Reinvestment Rate:8.9%
Fundamental Growth Rate (g):8.5%
Market-Implied Growth Rate:15.2%
Brina Gap:
-6.6%
☷ Click to view full A Brina Gap analysis →

Intrinsic Value Models (1)

Intrinsic Value:
$13.11B
📊 Click to view full A DCF valuation →

Margin of Safety (1)

Margin Of Safety:
-100.0%
📊 Click to view full A valuation analysis →

Return Scenarios (2)

Theoretical 5-Year Return:
-22.1%
📊 Click to view full A expected return analysis →
Forward Expected Return (Yield + Growth):
11.0%
📊 Click to view full A expected return analysis →

Investment Assessment (1)

Buffett Assessment:Overvalued
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (3)

Revenue Growth Rate (Linear):0.8%
Net Income Growth Rate (Linear):2.3%
Operating Income Growth Rate (Linear):0.6%

Cash Flow Growth Rates (2)

Free Cash Flow Growth Rate (Linear):-4.8%
Operating Cash Flow Growth Rate (Linear):-0.1%

Other Growth Rates (3)

Gross Profit Growth Rate (Linear):1.0%
Book Value Growth Rate (Linear):6.5%
Owner Earnings Growth Rate:-$0.55
C. Company Profile & Context

Corporate Information (6)

Symbol:A
Company Name:AGILENT TECHNOLOGIES, INC.
Sector:Unknown
Industry:Laboratory Analytical Instruments
Exchange:NYSE
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:high
Volume Category:N/A

Share Structure (3)

Shares Outstanding:282.00M
Shares Outstanding Basic:282.00M
Shares Outstanding Diluted:283.00M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-08-28 17:32:13 UTC
Data Timestamp:2026-08-28T17:32:13.768920
Scroll to Top